Streetbeat News

MGRM

Monogram Orthopaedics, Inc.

https://www.monogramorthopedics.com

Industry

Medical - Devices

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Open

2.57

Mkt cap

91M

Volume

110K

High

2.74

P/E Ratio

-5.66

52-wk high

4.90

Low

2.52

Div yield

N/A

52-wk low

1.53

In Friday's intraday session, several healthcare stocks experienced significant movements. PaxMedica (PXMD) led the gainers with a 110.9% increase, while Motus GI Holdings (MOTS) saw the largest decline at 39%. Other notable movers include Q32 Bio (QTTB), Cyclacel Pharmaceuticals (CYCCP), and Rani Therapeutics Holdings (RANI) among the gainers, and Monogram Orthopaedics (MGRM) and BioSig Technologies (BSGM) among the losers.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 4:31 pm

In Friday's pre-market session, several healthcare stocks showed significant movement. PaxMedica led the gainers with a 104.2% increase, while Motus GI Holdings experienced the largest drop among the losers, falling 26.1%. The movements reflect notable volatility in the healthcare sector, with companies ranging from biotech to pharmaceuticals experiencing shifts in their stock prices.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 12:09 pm

NextPlat Corp (NASDAQ:NXPL) shares surged approximately 30% in pre-market trading after announcing a 222% year-over-year increase in consolidated 2023 revenues, reaching $37.8 million. Other stocks also showed significant movement in pre-market trading, with notable gainers including Allarity Therapeutics, PaxMedica, OncoCyte Corporation, and Zapata Computing Holdings, among others. Conversely, several stocks experienced declines, such as Motus GI Holdings, Rent the Runway, and Kazia Therapeutics, driven by various company-specific news and market reactions.

Portfolio Pulse from Avi Kapoor

April 12, 2024 | 9:32 am

Monogram shares have seen an increase in trading volume and price following the announcement that the company has become a part of the NVIDIA Inception program, which is designed to nurture startups in AI and data sciences.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 7:44 pm

Monogram Orthopaedics shares have resumed trading, indicating a potential return to normal operations or the resolution of a previous issue that may have halted trading.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 6:06 pm

Monogram's stock was halted due to a circuit breaker trigger after it surged 25.1%, indicating a significant upward movement in its share price.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 5:23 pm

Monogram Orthopaedics Inc. (NASDAQ:MGRM) has been accepted into the NVIDIA Inception program, aimed at accelerating the development and commercialization of its mBôs robotic surgical system and related products. This collaboration will provide Monogram with access to NVIDIA's cutting-edge technology, expertise, and go-to-market support, potentially speeding up FDA clearance and product launch.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 5:22 pm

In Friday's pre-market session, several healthcare stocks showed significant movement. BIOL, OTLK, ETON, MGRM, OTRK, and NTRB were among the gainers, with BIOL leading by surging 61.5% after its Q4 earnings release. On the downside, SINT, CUTR, TBIO, GRFS, YTEN, and NKTX experienced declines, with SINT dropping 34%. CUTR and NKTX also released their Q4 earnings, impacting their stock prices.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 1:06 pm

Health care stocks showed significant movement in Thursday's intraday session, with notable gainers including Yield10 Bioscience, Monogram Orthopaedics, and X4 Pharmaceuticals, among others. Losers were led by Tourmaline Bio, Apyx Medical, and Ontrak. The movements were largely influenced by recent Q4 earnings reports.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 5:31 pm

Monogram Orthopaedics reported its FY23 earnings per share (EPS) at $(0.61), showing an improvement from last year's $(1.42). The company also reported a revenue of $364,999 for the fiscal year.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 12:36 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.